Anticancer agent 193
Anticancer agent 193 (compound D3-3) is an inducer of ferritinophagy, eventually triggering ferroptosis. Anticancer agent 193 induces the production of lipid ROS, and significantly promoted colorectal cancer cells to release the ferrous ion in an autophagy-dependent manner[1].
Product Specifications
CAS Number
[9007-83-4]
UNSPSC
12352005
Target
Autophagy; Ferroptosis; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-193.html
Solubility
10 mM in DMSO
Smiles
O=C(CCCCCCCCCCCNC(C(Cl)=C)=O)OC1=C2C(C[C@H](N(C)CC3)[C@](C=C4OC)([H])[C@@]23CC4=O)=CC=C1OC
Molecular Formula
C34H47ClN2O6
Molecular Weight
615.20
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162310/Anticancer-agent-193-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162310/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![5-Boc-2,5-diazaspiro[3.5]nonane oxalate](https://cdn.genprice.uk/genprice/genprice5.png)
Lentiviral human GLB1L3 shRNA (UAS) - Lentiviral human GLB1L3 shRNA (UAS, RFP) (100)